D1. Comparing the made distance in meters within a fixed time between a walker and a walk-bike used by COPD patients.D2. Comparing the walking time and distance on an outdoor track between a walker and a walk-bike used by COPD patients.
ID
Source
Brief title
Condition
- Respiratory disorders NEC
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Difference in made distance in meters within a fixed time between the walker
and the walkingbike used by COPD patients.
Difference in walking time and distance on an outdoor track between the walker
and the walkingbike used by COPD patients
Secondary outcome
Difference in symptom perception, number of stops, step distance, number of
steps, heart rate, oxygen uptake and ventilation within a fixed time between
the walker an the walk-bike used by COPD patients.
Difference in symptom perception, number of stops, step distance and number of
steps made on a fixed outdoor track between the walker an the walk-bike used by
COPD patients
Background summary
Patients with chronic obstructive pulmonary disease still have complaints of
shortness of breath and fatigue in daily functioning despite optimal
pharmaceutical treatment. Consequently they suffer from a limited mobility.
Study objective
D1. Comparing the made distance in meters within a fixed time between a walker
and a walk-bike used by COPD patients.
D2. Comparing the walking time and distance on an outdoor track between a
walker and a walk-bike used by COPD patients.
Study design
A prospective randomised controlled cross over trial.
Intervention
A rollator and a walk-bike.
Study burden and risks
The current research group believes that the nature and possible extent of the
burden and risks possibly related to the present protocol are nihil and
acceptable.
The mobile oxycon had been used in previous studies in healthy subjects and
patients with moderate to very severe COPD during exercise tests (for example:
Probst et al Chest 2004) and during extensive rehabilitation sessions (Probst
et al ERJ 2006) without any adverse events.
Universiteitssingel 50
6229 ER, Maastricht
NL
Universiteitssingel 50
6229 ER, Maastricht
NL
Listed location countries
Age
Inclusion criteria
Chronic Obstructive Pulmonary Disease (COPD).
A walking distance of < 500 meters in a 6-min walkingtest.
Exclusion criteria
Neurological disease
Neuromuscular disorder
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL24140.068.08 |
| Other | www.trialregister.nl |